Aswanth Reddy Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
faculty
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Aswanth Reddy's research focuses on the application of immunotherapies, particularly bispecific antibodies and antibody-drug conjugates, in the treatment of various cancers. His work investigates the role of these agents in targeting immune checkpoints and their efficacy in specific cancer types, including lung, colorectal, and breast cancer. Reddy has published reviews and case studies detailing the state-of-the-art in these therapeutic areas, examining genomic signatures and treatment outcomes in metastatic disease. He also studies the impact of genetic mutations and tumor markers in cancer progression and treatment response, as well as the management of specific hematological malignancies like chronic lymphocytic leukemia and the complex presentations of disseminated histoplasmosis in immunocompromised patients.
Metrics
- h-index: 4
- Publications: 31
- Citations: 39
Selected Publications
-
Abstract PS5-04-16: Analysis of Efficacy, Safety and Cost of Datopotamab Deruxtecan and Sacituzumab Govitecan for Advanced Hormone Positive Breast Cancer Patients (2026)
-
Performance of multiple multi-cancer detection tests using a large independent reference set (Alliance A212102) (2026)
-
Mortality trends of chronic lymphocytic leukemia and pneumonia in the United States (1999–2023): A CDC-wonder analysis (2025)
-
Efficacy, quality of life, and safety of non-clotting factor prophylaxis in Hemophilia A and b: A meta-analysis across inhibitor status (2025)
-
Rising mortality trends in elderly multiple myeloma patients with hypertension: A CDC wonder database analysis (1999–2023) (2025)
-
Comparative efficacy of complement inhibitors in complement Inhibitor–Naïve PNH: A network meta-analysis of randomized trials (2025)
-
AML-463: Unraveling a Unique Presentation of Cold Agglutinin Disease in Myeloid Malignancy (2025)
-
A Rare Finding of Secondary Spontanous Pneumothorax (SSP) During Tyrosine Kinase Inhibitor Treatment of a Patient With Metastatic Synovial Sarcoma (2025)
-
Treatment of Aggressive B Cell Lymphoma with Epcoritamab - Real World Single Institution Experience (2024)
-
EP.11A.22 Comparing Outcomes and Adverse Events in Lung Cancer Immunotherapy: The Impact of Smoking Status (2024)
-
MM-361 Central Nervous System Relapse of Multiple Myeloma: A Case Report (2024)
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics